The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 10.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 84%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (8 analysts) rates it strong buy, with a mean price target of $2.
DeFi Technologies Inc
DEFT · NASDAQ · USD · Market cap $206M · 26 employees
DeFi Technologies Inc., a technology company, develops exchange traded products that synthetically track the value of a single DeFi protocol or a basket of protocols in Canada.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price0.32 USD at the 13 Nov 2026 close
- Fair value0.25. Our model only; the analyst targets sit too far from the price to cross-check it.
- Our value readOvervalued vs our fair value, as of 13 Nov 2026
- Our regime readMarkdown, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.38)
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $0.25 to $0.45, base estimate $0.25 (screen dated 2026-11-13).
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
DeFi Technologies Inc holds its Markdown at $0.32. Elevated stress, defensive posture warranted, held for 35 days.
| Phase | Markdown · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 35 days |
| Price at the screen | $0.32 |
| Valuation | 7.25 trailing · 16.92 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 4.01 |
Five Screens, Shown in Full
Does not pass. Excluded industry: Capital Markets
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Excluded industry: Capital Markets | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
DeFi Technologies does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when DEFT's ethical verdict changes
Today DEFT does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our model only; the analyst targets sit too far from the price to cross-check it.
Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $0.25 fair value estimate, none competitive moat.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 30.0% above the base estimate.
Third-party analyst targets: 8 covering, consensus Strong Buy. The average target sits +396% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $0.25, with a range of $0.25 to $0.45, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
At 16.9x forward earnings, the price already runs ahead of the business. It trades 30% above our $0.25 fair value, so you would be buying at a premium, not a discount. The none moat is real, but quality alone does not make an expensive price cheap.
| Forward P/E | 16.9xreasonably valued |
| Trailing P/E | 7.3xvery cheap relative to earnings |
| EPS, trailing | 0.08 |
| EPS, forward | 0.03 |
| Revenue growth | -74.4%revenue is shrinking |
| Profit margin | 56.1%highly profitable on every dollar of sales |
| Return on equity | 35.3%an exceptional return on shareholder capital |
| Debt to equity | 1.90a meaningful debt load worth watching |
| Beta | 4.01much more volatile than the market |
| 52-week range | 0.47 - 3.59 |
| Moat | NONE |
| Market cap | $206M |
| Employees | 26 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeDEFT trades on NASDAQ (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 24.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 84%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (8 analysts) rates it strong buy, with a mean price target of $2.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 84%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (8 analysts) rates it strong buy, with a mean price target of $2.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 8.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 84%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (8 analysts) rates it strong buy, with a mean price target of $2. Since the last review it entered the Titan Ethical 500; its quality tier rose to Gold; its composite score rose.
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 84%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (8 analysts) rates it strong buy, with a mean price target of $2.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 84%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (8 analysts) rates it strong buy, with a mean price target of $2.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 84%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (8 analysts) rates it strong buy, with a mean price target of $2.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $0.74 | -28.3% | · | $717 | -28.3% |
| 2 months | $0.74 | -28.7% | · | $713 | -28.7% |
| 3 months | $0.64 | -17.3% | · | $827 | -17.3% |
| 6 months | $1.13 | -53.2% | · | $468 | -53.2% |
| 1 year | $3.31 | -84.0% | · | $160 | -84.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever DEFT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.